Zenara Pharma Private Limited, a active private limited company, was established on 18 March 2004 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2004PTC042894. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹48.24 Cr.
Formerly known as Danmed Pharmaceuticals Private Limited. It upholds a compliant status. Employing 205 professional, Its leadership includes Manikreddy Pullagurla (Director), Jagadeesh Babu Rangisetty (Director). Past directors included Manikreddy Pullagurla, Ajay Swengly, Bela Chordia. It holds ₹6.20 M open charges and ₹18.89 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 83/B, 84, 87-96, Phase Iii, Ida, Cherlapally, Hyderabad, Telangana, 500051.
U24239TG2004PTC042894
042894
18 March 2004
₹50.00 Cr
₹48.24 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Zenara Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manikreddy Pullagurla | Director | 21 Jan 2017 | Current |
| Jagadeesh Babu Rangisetty | Director | 21 Jan 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Whole-Time Director | 21 Jan 2017 | Past |
| Pramod Abcsdd | Director | 06 Dec 2007 | Past |
| Pramod Abcsdd | Director | 25 Mar 2015 | Past |
| Pramod Abcsdd | Additional Director | 15 Sep 2011 | Past |
| Pramod Abcsdd | Director | 06 Dec 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zenara Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 76.5% increase. The company also saw a substantial improvement in profitability, with a 148.6% increase in profit. The company's net worth Soared by an impressive increase of 17.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Zenara Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,204,180.00
₹188,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2025 | Hdfc Bank Limited | ₹6.20 M | Open |
| 31 Aug 2021 | Others | ₹5.74 Cr | Satisfied |
| 28 Dec 2017 | Others | ₹2.85 Cr | Satisfied |
| 24 Jun 2005 | The South Indian Bank Limited | ₹10.30 Cr | Satisfied |
Explore comprehensive loan charge details -
Zenara Pharma has a workforce of 205 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zenara Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenara Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 28 Dec 2017 via Charge ID 100146903 with Others was fully satisfied on 13 Nov 2025. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.62 Cr with Charge ID 101158509 was registered on 01 Aug 2025. was documented.
Zenara Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge registered on 31 Aug 2021 via Charge ID 100483421 with Others was fully satisfied on 15 Apr 2024. was recorded as a recent event.
Progress on Zenara Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
A charge with Others of Rs. 2.85 Cr registered on 28 Dec 2017 with Charge ID 100146903 was modified on 07 Nov 2023. was recorded as a recent event.
The CIN of Zenara Pharma Private Limited is U24239TG2004PTC042894.
Zenara Pharma Private Limited is headquartered at Plot No. 83/B, 84, 87-96, Phase Iii, Ida, Cherlapally, Hyderabad, Telangana, 500051.
Zenara Pharma Private Limited was incorporated on 18 March 2004.
The current directors of Zenara Pharma Private Limited are
The primary industry of Zenara Pharma Private Limited is Manufacturing.
Zenara Pharma Private Limited is unlisted.
The authorized capital of Zenara Pharma Private Limited is ₹50.00 Cr, and the paid-up capital is ₹48.24 Cr.
The compliance status of Zenara Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX